TABLE 2.
Sample identifier | Mean sample concentrations (EU/ml)b | No. of resultsc | % of determinations scored as: |
||
---|---|---|---|---|---|
Negative (ODS < ODCII) | Intermediate (ODS ≥ ODCII and < ODCIII) | Positive (ODS ≥ ODCIII) | |||
S1 | < 15 | 39 | 100 | 0 | 0 |
S2 | 32 | 32 | 91 | 9 | 0 |
S3 | 53 | 104 | 42 | 54 | 4 |
S4 | 74 | 99 | 3 | 71 | 26 |
S5 | 100 | 34 | 0 | 26 | 74 |
S6 | 109 | 34 | 3 | 21 | 76 |
S7 | 148 | 97 | 0 | 0 | 100 |
S8 | 230 | 93 | 1 | 0 | 99 |
The OD of samples (ODS) were compared with the OD of controls CII and CIII (ODCII and ODCIII, respectively). Boldface (samples S3 and S4) indicates those samples with an IgG anti-PT concentration between those of CII (49 EU/ml) and CIII (94 EU/ml).
ELISA units/ml.
All results from valid plates were used provided that the %CV criteria were met for CII, CIII, and sample. Qualitative analyses were based solely on ODs; no results were excluded based on calculated values of <15 EU/ml or >480 EU/ml.